ERBB2 and neoplasm: In this study, we have reviewed women diagnosed with stage I (T1N0M0) tumours at our unit to examine the recurrence patterns and evaluate the impact of adjuvant systemic chemotherapy and anti-HER2 therapy on survival outcomes.